Regeneus gets a few mentions.
Should be an interesting few weeks coming up with the reporting of the phase 1 Prgenza trial.
Mesoblast is really firing share price wise at the moment.
RGS in clinic and on the cusp of moving into phase II trial
http://www.copyright link/business/...ng-with-australian-technology-20170425-gvrpo9
AFR article on regenerative medicine in Japan
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
